Correlation Between Cannara Biotech and 4Front Ventures

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and 4Front Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and 4Front Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and 4Front Ventures Corp, you can compare the effects of market volatilities on Cannara Biotech and 4Front Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of 4Front Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and 4Front Ventures.

Diversification Opportunities for Cannara Biotech and 4Front Ventures

-0.28

Correlation Coefficient

Cannara Biotech  4Front Ventures

Very good diversification

The 3 months correlation between Cannara and 4Front is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and 4Front Ventures Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4Front Ventures Corp and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with 4Front Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4Front Ventures Corp has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and 4Front Ventures go up and down completely randomly.

Pair Corralation between Cannara Biotech and 4Front Ventures

Assuming the 90 days horizon Cannara Biotech is expected to generate 0.68 times more return on investment than 4Front Ventures. However, Cannara Biotech is 1.46 times less risky than 4Front Ventures. It trades about 0.11 of its potential returns per unit of risk. 4Front Ventures Corp is currently generating about -0.11 per unit of risk. If you would invest  45.00  in Cannara Biotech on September 12, 2024 and sell it today you would earn a total of  5.00  from holding Cannara Biotech or generate 11.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  4Front Ventures Corp

Cannara Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

4Front Ventures Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days 4Front Ventures Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Cannara Biotech and 4Front Ventures

The main advantage of trading using opposite Cannara Biotech and 4Front Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, 4Front Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4Front Ventures will offset losses from the drop in 4Front Ventures' long position.

The idea behind Cannara Biotech and 4Front Ventures Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.